AGN another box ticked! spoke to a pharma science buddy who noted that it's very rare for pre-clinical bio drugs to demonstrate no negative reciprocal effects when testing on animals. Recent peer reviews also seem to show conviction in ARG-007, on top of this the market is not only a monopoly in terms of effectiveness and method and efficiency of administering, but it's a bloody big one!
Worth a study, I know this a DT forum but I've been following since IPO and it seems like a unicorn in the making
would love to hear someone else's perspective!
cheers
- Forums
- ASX - Day Trading
- Morning trading May 19
Morning trading May 19, page-83
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online